Dr Caroline Binda
Timau a rolau for Caroline Binda
Cynorthwy-ydd Ymchwil, Is-adran Meddygaeth Seicolegol a Niwrowyddorau Clinigol
Cyhoeddiad
2026
- Binda, C. et al. 2026. Inhibiting PMS1 ATPase activity reduces somatic CAG repeat expansion in Huntington’s disease iPSCs [Conference Abstract]. Journal of Neurology, Neurosurgery and Psychiatry 97 (Supp 2) A30. (10.1136/jnnp-2026-ehdn.75)
- Stone, J. et al. 2026. An inducible human neuronal model for evaluating therapeutic modulation of somatic CAG repeat expansion in Huntington’s disease [Conference Abstract]. Journal of Neurology, Neurosurgery and Psychiatry 97 (Supp 2) A148. (10.1136/jnnp-2026-ehdn.332)
2023
- Stöberl, N. et al. 2023. Mutant huntingtin confers cell-autonomous phenotypes on Huntington’s disease iPSC-derived microglia. Scientific Reports 13 20477. (10.1038/s41598-023-46852-z)
2022
- McAllister, B. et al. 2022. Exome sequencing of individuals with Huntington’s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset. Nature Neuroscience 25 , pp.446-457. (10.1038/s41593-022-01033-5)
Articles
- Binda, C. et al. 2026. Inhibiting PMS1 ATPase activity reduces somatic CAG repeat expansion in Huntington’s disease iPSCs [Conference Abstract]. Journal of Neurology, Neurosurgery and Psychiatry 97 (Supp 2) A30. (10.1136/jnnp-2026-ehdn.75)
- Stone, J. et al. 2026. An inducible human neuronal model for evaluating therapeutic modulation of somatic CAG repeat expansion in Huntington’s disease [Conference Abstract]. Journal of Neurology, Neurosurgery and Psychiatry 97 (Supp 2) A148. (10.1136/jnnp-2026-ehdn.332)
- Stöberl, N. et al. 2023. Mutant huntingtin confers cell-autonomous phenotypes on Huntington’s disease iPSC-derived microglia. Scientific Reports 13 20477. (10.1038/s41598-023-46852-z)
- McAllister, B. et al. 2022. Exome sequencing of individuals with Huntington’s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset. Nature Neuroscience 25 , pp.446-457. (10.1038/s41593-022-01033-5)